Authors' reply to Aaby et al
- J Vaugelade, demographer (vaugelad@ird.fr),
- F Simondon, epidemiologist,
- E Elguero, statistician,
- S Pinchinat, biostatistician,
- G Guiella, researcher
- Institut de Recherche pour le Développement, Laboratoire Population, Environnement et Développement, BP 64501, 34394 Montpellier Cedex 5, France
- Biostatem, Parc Scientifique G Besse, F 30035 Nîmes, France
- Unité d'Etudes et de Recherche en Démographie, 03 BP 7118, Ouagadougou 03, Burkina Faso
EDITOR—Aaby et al raise issues of general rather than specific interest, as their references indicate. The study of the effects of vaccines, which pioneered the randomised controlled trials method more than 50 years ago, is still topical and of general interest.1 The limitations discussed by Aaby et al …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
Re: On the impossibility of being expert
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012